2025D3/PENTA 21 trialStudiesOnce-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trialREAD MORE
2025Paediatric Post-Tuberculosis Study (PPT Study)StudiesPost-TB lung function, quality of life, and radiographic findings in childrenREAD MORE
2025Birth Defects SurveillanceStudiesPrevalence, trends, and maternal risk factors of adverse birth outcomes from a hospital-based birth defects surveillance system in Kampala, Uganda, 2015–2022READ MORE
2025MTN-042StudiesExploring pregnant women’s experiences with dapivirine vaginal ring insertion during the MTN-042/DELIVER study in Uganda: a description of secondary dataREAD MORE
2025Maternal and Childhood VaccinesStudiesEpidemiology of Group B Streptococcus: Maternal Colonization and Infant Disease in Kampala, UgandaREAD MORE
2025HPTN 084-01StudiesSafety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trialREAD MORE
2025PROGRESSStudiesSeroprevalence of Cytomegalovirus Among Pregnant Women at Kawempe National Referral Hospital, Uganda: A Cross-sectional StudyREAD MORE
2025PROGRESSStudiesRapid Point-of-care Testing to Inform Intrapartum Treatment of Group B Streptococcus–Colonized Women in UgandaREAD MORE
2025PROGRESSStudiesInfectious Causes of Stillbirths: A Descriptive Etiological Study in UgandaREAD MORE
